Committee roundup: key committee recommendations from March 4

The Senate Judiciary Committee moved a slate of measures on March 4 and recommended them to the Senate floor. The committee took formal action on several bills and one concurrent resolution; notable committee actions included:

- SGR 17 (AI legislative‑summary resolution): Committee favorably recommended (vote recorded as 3–1).
- HB 138 (second substitute): Child‑abuse homicide amendments; favorably recommended (committee recorded motion passing; transcript records 3–1 in one instance and unanimous language in another; sponsors to finalize drafting).
- HB 547 (substitute): Penalty enhancements for transnational repression; favorably recommended (committee recorded 6–0).
- HB 442 (seventh substitute): Menstrual‑product ingredient disclosure with implementation timelines; favorably recommended (committee recorded unanimous support in discussion).
- HB 315 (second substitute): Fetal‑development minimum video standard in health; favorably recommended (vote recorded 4–2 with Pitcher and Escamilla voting no).
- HB 450, HB 539, HB 590 (as amended), HB 591 (second substitute) and HCR 9 (Great Salt Lake concurrent resolution) were also favorably recommended; the committee recorded those motions as passing in the session.

Committee members and witnesses noted areas for follow‑up: vendors and enforcement language on HB 442; statutory drafting on HB 138 regarding ‘‘direct and proximate’’ causation; USBE coordination and medical‑accuracy concerns for HB 315; and training/implementation details for HB 547. The committee adjourned at the end of the scheduled hearing.

Why it matters: The measures recommended span criminal law, consumer protection, education policy and public‑safety provisions; several require follow‑up drafting and interagency coordination before floor action.

Next steps: Each favorably recommended bill will be scheduled for floor consideration; sponsors and committee staff indicated planned follow‑up work where drafting or implementation details remain outstanding.